Open access · CC-BY
via OpenAlex
A comprehensive review on the neuroprotective potential of resveratrol in ischemic stroke
Maryam Owjfard, Zahra Rahimian, Farzaneh Karimi, Afshin Borhani‐Haghighi, Arashk Mallahzadeh
Heliyon · 2024 · ▲ 41 citations
Deregulated nutrient-sensing
Mitochondrial dysfunction
Chronic inflammation
Human
Preclinical / animal
Review
Abstract
Stroke is the second leading cause of death and the third leading cause of disability worldwide. Globally, 68 % of all strokes are ischemic, with 32 % being hemorrhagic. Ischemic stroke (IS) poses significant challenges globally, necessitating the development of effective therapeutic strategies. IS is among the deadliest illnesses. Major functions are played by neuroimmunity, inflammation, and oxidative stress in the multiple intricate pathways of IS. Secondary brain damage is specifically caused by the early pro-inflammatory activity that follows cerebral ischemia, which is brought on by excessive activation of local microglia and the infiltration of circulating monocytes and macrophages. Resveratrol, a natural polyphenol found in grapes and berries, has shown promise as a neuroprotective agent in IS. This review offers a comprehensive overview of resveratrol's neuroprotective role in IS, focusing on its mechanisms of action and therapeutic potential. Resveratrol exerts neuroprotective effects by activating nuclear factor erythroid 2-related factor 2 (NRF2) and sirtuin 1 (SIRT1) pathways. SIRT1 activation by resveratrol triggers the deacetylation and activation of downstream targets like peroxisome proliferator-activated receptor-gamma coactivator 1 alpha (PGC-1α) and forkhead box protein O (FOXO), regulating mitochondrial biogenesis, antioxidant defense, and cellular stress response. Consequently, resveratrol promotes cellular survival and inhibits apoptosis in IS. Moreover, resveratrol activates the NRF2 pathway, a key mediator of the cellular antioxidant response. Activation of NRF2 through resveratrol enhances the expression of antioxidant enzymes, like heme oxygenase-1 (HO-1) and NAD(P)H quinone oxidoreductase 1 (NQO1), which neutralize reactive oxygen species and mitigate oxidative stress in the ischemic brain. Combined, the activation of SIRT1 and NRF2 pathways contributes to resveratrol's neuroprotective effects by reducing oxidative stress, inflammation, and apoptosis in IS. Preclinical studies demonstrate that resveratrol improves functional outcomes, reduces infarct size, regulates cerebral blood flow and preserves neuronal integrity. Gaining a comprehensive understanding of these mechanisms holds promise for the development of targeted therapeutic interventions aimed at promoting neuronal survival and facilitating functional recovery in IS patients and to aid future studies in this matter.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1016/j.heliyon.2024.e34121
- Canonical
- link ↗
- Fetched
- 2026-10-11 MST
Cite this
APA
Owjfard, M., Rahimian, Z., Karimi, F., Borhani‐Haghighi, A., & Mallahzadeh, A. (2024). A comprehensive review on the neuroprotective potential of resveratrol in ischemic stroke. <em>Heliyon</em>. https://doi.org/10.1016/j.heliyon.2024.e34121
Vancouver
Owjfard M, Rahimian Z, Karimi F, Borhani‐Haghighi A, Mallahzadeh A. A comprehensive review on the neuroprotective potential of resveratrol in ischemic stroke. Heliyon. 2024. doi:10.1016/j.heliyon.2024.e34121.
BibTeX
@article{maryam2024Acompr,
title = {A comprehensive review on the neuroprotective potential of resveratrol in ischemic stroke},
author = {Maryam Owjfard and Zahra Rahimian and Farzaneh Karimi and Afshin Borhani‐Haghighi and Arashk Mallahzadeh},
journal = {Heliyon},
year = {2024},
doi = {10.1016/j.heliyon.2024.e34121},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Pharmaceuticals 2009
Open access · CC-BY
Resveratrol: An Antiaging Drug with Potential Therapeutic Applications in Treating Diseases
Molecular medicine reports 2026
Open access · OA
SIRT1/AMPK/PGC1α pathway in ischemic stroke: Elucidating neuroprotective strategies (Review).
Medical Science Monitor 2011
Open access · CC-BY
SIRT1 as a potential therapeutic target for treatment of nonalcoholic fatty liver disease
Frontiers in Endocrinology 2020
Open access · CC-BY
SIRT1 Antagonizes Oxidative Stress in Diabetic Vascular Complication
Planta Medica 2024
Open access · OA
Phytoestrogens and Sirtuin Activation for Renal Protection: A Review of Potential Therapeutic Strategies
Nutrients 2026
Open access · OA